These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Therapy of dilated cardiomyopathies with and without inflammation]. Hufnagel G; Pankuweit S; Maisch B Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534 [TBL] [Abstract][Full Text] [Related]
6. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438 [TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?]. Schultheiss HP Internist (Berl); 1992 Oct; 33(10):650-62. PubMed ID: 1428684 [No Abstract] [Full Text] [Related]
8. Use of OKT3 for acute myocarditis in infants and children. Ahdoot J; Galindo A; Alejos JC; George B; Burch C; Marelli D; Sadeghi A; Laks H J Heart Lung Transplant; 2000 Nov; 19(11):1118-21. PubMed ID: 11077231 [TBL] [Abstract][Full Text] [Related]
9. Lessons from animal experiments in myocarditis. Matsumori A Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548 [TBL] [Abstract][Full Text] [Related]
10. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy]. Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062 [No Abstract] [Full Text] [Related]
12. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Maisch B; Herzum M; Hufnagel G; Bethge C; Schönian U Eur Heart J; 1995 Dec; 16 Suppl O():153-61. PubMed ID: 8682087 [TBL] [Abstract][Full Text] [Related]
13. Global biventricular dysfunction in patients with asymptomatic coronary artery disease may be caused by myocarditis. Frustaci A; Chimenti C; Maseri A Circulation; 1999 Mar; 99(10):1295-9. PubMed ID: 10077512 [TBL] [Abstract][Full Text] [Related]
14. Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis. Silverblatt JA; Ziff OJ; Dancy L; Daniel A; Carter B; Scott P; Sado DM; Shah A; Bromage DI Basic Res Cardiol; 2019 Oct; 114(6):48. PubMed ID: 31673885 [TBL] [Abstract][Full Text] [Related]
15. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Kawai C Circulation; 1999 Mar; 99(8):1091-100. PubMed ID: 10051305 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Godsel LM; Leon JS; Engman DM Curr Pharm Des; 2003; 9(9):723-35. PubMed ID: 12570790 [TBL] [Abstract][Full Text] [Related]
17. Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology. Miranda JO; Costa L; Rodrigues E; Teles EL; Baptista MJ; Areias JC Cardiol Young; 2015 Feb; 25(2):333-7. PubMed ID: 24423967 [TBL] [Abstract][Full Text] [Related]
18. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
19. Medical management of mild-to-moderate heart failure before the advent of beta blockers. Abraham WT; Wagoner LE Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776 [TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic options in inflammatory cardiomyopathy. Kania G; Blyszczuk P; Müller-Edenborn B; Eriksson U Swiss Med Wkly; 2013; 143():w13841. PubMed ID: 23986269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]